Table 2.

Complex survey-weighted regression analysis of TyG-ABSI and risks of CVD, cardiovascular mortality, and all-cause mortality

Exposure	Outcome	Model 1		Model 2		Model 3
		OR(95%CI)	P-value	OR(95%CI)	p-value	OR(95%CI)	p-value
TyG-ABSI	CVD	1.89 (1.73 ~ 2.06)	< 0.001	1.39 (1.25 ~ 1.55)	< 0.001	1.28 (1.15 ~ 1.43)	< 0.001
TyG-ABSI tertile
T1 (lowest)		Reference		Reference		Reference
T2 (middle)		1.77 (1.48 ~ 2.12)	< 0.001	1.23 (1.00 ~ 1.50)	0.048	1.09 (0.89 ~ 1.35)	0.396
T3 (highest)		3.19 (2.66 ~ 3.82)	< 0.001	1.75 (1.43 ~ 2.14)	< 0.001	1.48 (1.20 ~ 1.83)	< 0.001
P for trend		< 0.001		< 0.001		< 0.001
		HR(95%CI)	P-value	HR(95%CI)	p-value	HR(95%CI)	p-value
TyG-ABSI	Cardiovascular mortality	1.83 (1.63 ~ 2.06)	< 0.001	1.26 (1.10 ~ 1.47)	0.003	1.25 (1.08 ~ 1.45)	0.003
TyG-ABSI tertile
T1 (lowest)		Reference		Reference		Reference
T2 (middle)		1.99 (1.46 ~ 2.71)	< 0.001	1.18 (0.87 ~ 1.62)	0.288	1.25 (0.90 ~ 1.73)	0.193
T3 (highest)		3.11 (2.35 ~ 4.12)	< 0.001	1.37 (1.01 ~ 1.85)	0.043	1.40 (1.02 ~ 1.92)	0.036
P for trend		< 0.001		0.037		0.032
TyG-ABSI	All-cause mortality	1.85 (1.72 ~ 1.98)	< 0.001	1.30 (1.20 ~ 1.42)	< 0.001	1.28 (1.16 ~ 1.40)	< 0.001
TyG-ABSI tertile
T1 (lowest)		Reference		Reference		Reference
T2 (middle)		1.71 (1.43 ~ 2.05)	< 0.001	1.06 (0.89 ~ 1.27)	0.514	1.08 (0.88 ~ 1.31)	0.478
T3 (highest)		2.92 (2.52 ~ 3.38)	< 0.001	1.37 (1.17 ~ 1.60)	< 0.001	1.34 (1.11 ~ 1.61)	0.002
P for trend		< 0.001		< 0.001		< 0.001

Model 1: No adjustment; Model 2: Adjusted for age, gender, and race; Model 3: Additionally adjusted for marital status, education, PIR, smoking, alcohol use, cancer, CKD, BMI, total energy intake, TC, LDL-C, BUN, UA, Cr, ALT, AST, ALB, TBil, antidiabetic medication use, statin use, antihypertensive use